Genotype-Phenotype correlation in Dravet Syndrome with SCN1A mutation increase efficiency of molecular diagnosis

Detalhes bibliográficos
Autor(a) principal: Gonsales,MC
Data de Publicação: 2012
Outros Autores: Preto,P, Montenegro,MA, Guerreiro,MM, Lopes-Cendes,I
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Journal of epilepsy and clinical neurophysiology (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-26492012000200009
Resumo: OBJECTIVES: The purpose of this study was to advance the knowledge on the clinical use of SCN1A testing for severe epilepsies within the spectrum of generalized epilepsy with febrile seizures plus by performing genetic screening in patients with Dravet and Doose syndromes and establishing genotype-phenotype correlations. METHODS: Mutation screening in SCN1A was performed in 15 patients with Dravet syndrome and 13 with Doose syndrome. Eight prediction algorithms were used to analyze the impact of the mutations in putative protein function. Furthermore, all SCN1A mutations previously published were compiled and analyzed. In addition, Multiplex Ligation-Dependent Probe Amplification (MLPA) technique was used to detect possible copy number variations within SCN1A. RESULTS: Twelve mutations were identified in patients with Dravet syndrome, while patients with Doose syndrome showed no mutations. Our results show that the most common type of mutation found is missense, and that they are mostly located in the pore region and the N- and C-terminal of the protein. No copy number variants in SCN1A were identified in our cohort. CONCLUSIONS: SCN1A testing is clinically useful for patients with Dravet syndrome, but not for those with Doose syndrome, since both syndromes do not seem to share the same genetic basis. Our results indicate that indeed missense mutations can cause severe phenotypes depending on its location and the type of amino-acid substitution. Moreover, our strategy for predicting deleterious effect of mutations using multiple computation algorithms was efficient for most of the mutations identified.
id LBE-1_103fbcc4cd39c3c15a1549cba61cf27a
oai_identifier_str oai:scielo:S1676-26492012000200009
network_acronym_str LBE-1
network_name_str Journal of epilepsy and clinical neurophysiology (Online)
repository_id_str
spelling Genotype-Phenotype correlation in Dravet Syndrome with SCN1A mutation increase efficiency of molecular diagnosisgenetic testingmutationssodium channelOBJECTIVES: The purpose of this study was to advance the knowledge on the clinical use of SCN1A testing for severe epilepsies within the spectrum of generalized epilepsy with febrile seizures plus by performing genetic screening in patients with Dravet and Doose syndromes and establishing genotype-phenotype correlations. METHODS: Mutation screening in SCN1A was performed in 15 patients with Dravet syndrome and 13 with Doose syndrome. Eight prediction algorithms were used to analyze the impact of the mutations in putative protein function. Furthermore, all SCN1A mutations previously published were compiled and analyzed. In addition, Multiplex Ligation-Dependent Probe Amplification (MLPA) technique was used to detect possible copy number variations within SCN1A. RESULTS: Twelve mutations were identified in patients with Dravet syndrome, while patients with Doose syndrome showed no mutations. Our results show that the most common type of mutation found is missense, and that they are mostly located in the pore region and the N- and C-terminal of the protein. No copy number variants in SCN1A were identified in our cohort. CONCLUSIONS: SCN1A testing is clinically useful for patients with Dravet syndrome, but not for those with Doose syndrome, since both syndromes do not seem to share the same genetic basis. Our results indicate that indeed missense mutations can cause severe phenotypes depending on its location and the type of amino-acid substitution. Moreover, our strategy for predicting deleterious effect of mutations using multiple computation algorithms was efficient for most of the mutations identified.Liga Brasileira de Epilepsia (LBE)2012-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-26492012000200009Journal of Epilepsy and Clinical Neurophysiology v.18 n.2 2012reponame:Journal of epilepsy and clinical neurophysiology (Online)instname:Liga Brasileira de Epilepsia (LBE)instacron:LBE10.1590/S1676-26492012000200009info:eu-repo/semantics/openAccessGonsales,MCPreto,PMontenegro,MAGuerreiro,MMLopes-Cendes,Ieng2012-12-07T00:00:00Zoai:scielo:S1676-26492012000200009Revistahttp://epilepsia.org.br/publicacoes/ONGhttps://old.scielo.br/oai/scielo-oai.php||jecnpoa@terra.com.br1980-53651676-2649opendoar:2012-12-07T00:00Journal of epilepsy and clinical neurophysiology (Online) - Liga Brasileira de Epilepsia (LBE)false
dc.title.none.fl_str_mv Genotype-Phenotype correlation in Dravet Syndrome with SCN1A mutation increase efficiency of molecular diagnosis
title Genotype-Phenotype correlation in Dravet Syndrome with SCN1A mutation increase efficiency of molecular diagnosis
spellingShingle Genotype-Phenotype correlation in Dravet Syndrome with SCN1A mutation increase efficiency of molecular diagnosis
Gonsales,MC
genetic testing
mutations
sodium channel
title_short Genotype-Phenotype correlation in Dravet Syndrome with SCN1A mutation increase efficiency of molecular diagnosis
title_full Genotype-Phenotype correlation in Dravet Syndrome with SCN1A mutation increase efficiency of molecular diagnosis
title_fullStr Genotype-Phenotype correlation in Dravet Syndrome with SCN1A mutation increase efficiency of molecular diagnosis
title_full_unstemmed Genotype-Phenotype correlation in Dravet Syndrome with SCN1A mutation increase efficiency of molecular diagnosis
title_sort Genotype-Phenotype correlation in Dravet Syndrome with SCN1A mutation increase efficiency of molecular diagnosis
author Gonsales,MC
author_facet Gonsales,MC
Preto,P
Montenegro,MA
Guerreiro,MM
Lopes-Cendes,I
author_role author
author2 Preto,P
Montenegro,MA
Guerreiro,MM
Lopes-Cendes,I
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Gonsales,MC
Preto,P
Montenegro,MA
Guerreiro,MM
Lopes-Cendes,I
dc.subject.por.fl_str_mv genetic testing
mutations
sodium channel
topic genetic testing
mutations
sodium channel
description OBJECTIVES: The purpose of this study was to advance the knowledge on the clinical use of SCN1A testing for severe epilepsies within the spectrum of generalized epilepsy with febrile seizures plus by performing genetic screening in patients with Dravet and Doose syndromes and establishing genotype-phenotype correlations. METHODS: Mutation screening in SCN1A was performed in 15 patients with Dravet syndrome and 13 with Doose syndrome. Eight prediction algorithms were used to analyze the impact of the mutations in putative protein function. Furthermore, all SCN1A mutations previously published were compiled and analyzed. In addition, Multiplex Ligation-Dependent Probe Amplification (MLPA) technique was used to detect possible copy number variations within SCN1A. RESULTS: Twelve mutations were identified in patients with Dravet syndrome, while patients with Doose syndrome showed no mutations. Our results show that the most common type of mutation found is missense, and that they are mostly located in the pore region and the N- and C-terminal of the protein. No copy number variants in SCN1A were identified in our cohort. CONCLUSIONS: SCN1A testing is clinically useful for patients with Dravet syndrome, but not for those with Doose syndrome, since both syndromes do not seem to share the same genetic basis. Our results indicate that indeed missense mutations can cause severe phenotypes depending on its location and the type of amino-acid substitution. Moreover, our strategy for predicting deleterious effect of mutations using multiple computation algorithms was efficient for most of the mutations identified.
publishDate 2012
dc.date.none.fl_str_mv 2012-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-26492012000200009
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-26492012000200009
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S1676-26492012000200009
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Liga Brasileira de Epilepsia (LBE)
publisher.none.fl_str_mv Liga Brasileira de Epilepsia (LBE)
dc.source.none.fl_str_mv Journal of Epilepsy and Clinical Neurophysiology v.18 n.2 2012
reponame:Journal of epilepsy and clinical neurophysiology (Online)
instname:Liga Brasileira de Epilepsia (LBE)
instacron:LBE
instname_str Liga Brasileira de Epilepsia (LBE)
instacron_str LBE
institution LBE
reponame_str Journal of epilepsy and clinical neurophysiology (Online)
collection Journal of epilepsy and clinical neurophysiology (Online)
repository.name.fl_str_mv Journal of epilepsy and clinical neurophysiology (Online) - Liga Brasileira de Epilepsia (LBE)
repository.mail.fl_str_mv ||jecnpoa@terra.com.br
_version_ 1754734659787292672